Save on Respiratory Syncytial Virus Vaccine with Coupons, Discounts & Savings Programs

Respiratory Syncytial Virus Vaccine is available as an intramuscular injection.

Respiratory Syncytial Virus Vaccine is a vaccine and is used for the following:

• Prevention of respiratory syncytial virus (RSV) in:
• Adults ages 60 years and older
• Pregnant females between 32 to 36 weeks of pregnancy

Respiratory Syncytial Virus Vaccine is a recombinant protein subunit vaccine, meaning pieces of the virus are made and put into the vaccine. It helps protect you from respiratory syncytial virus (RSV) infection by triggering your immune system to make proteins called antibodies against the virus. These antibodies will help prevent infection by attacking the virus if it ever infects your body.

Respiratory Syncytial Virus Vaccine is dosed as 0.5 mL injected into the muscle by a healthcare provider.

Respiratory Syncytial Virus Vaccine is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

Common side effects of Respiratory Syncytial Virus Vaccine:

• Tiredness
• Headache
• Pain at injection site
• Muscle pain
• Pregnant females:
• Pain at injection site
• Tiredness
• Headache
• Muscle pain
• Nausea

Serious side effects are rare with Respiratory Syncytial Virus Vaccine. Contact your healthcare provider immediately if you experience any of the following.

• Severe allergic reaction: hives, racing heart, difficulty breathing, swelling of the face, lips, tongue, or throat

There are no major drug interactions listed for Respiratory Syncytial Virus Vaccine. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.

Various FDA-approved generic manufacturers

Respiratory Syncytial Virus Vaccine is a vaccine indicated for active immunization of pregnant individuals at 32 through 36 weeks
gestational age for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by
respiratory syncytial virus (RSV) in infants from birth through 6 months of age. There is a pregnancy exposure registry that monitors pregnancy outcomes in individuals exposed to Respiratory Syncytial Virus Vaccine during pregnancy. Individuals who received Respiratory Syncytial Virus Vaccine during pregnancy are encouraged to contact, or have their healthcare provider contact, 1-800-616-3791 to enroll in or obtain information about the registry.

• Abrysvo